冷却射频与传统射频治疗膝神经慢性膝痛:COCOGEN试验12个月及成本效果结果
COCOGEN双盲非劣效随机对照试验比较冷却射频与传统射频治疗骨关节炎或全膝关节置换术后持续性术后疼痛的慢性膝痛患者,随访12个月。两组约22%患者疼痛减轻≥50%,差异无统计学意义;在持续性术后疼痛患者中,冷却射频在12个月时平均绝对NRS评分有统计学显著差异,且成本更低、QALY更高,未发生严重不良事件。
要点
- 两组约22%患者12个月疼痛减轻≥50%,总体差异无统计学意义。
- 持续性术后疼痛患者中冷却射频12个月平均绝对NRS评分与传统射频有显著差异。
- 持续性术后疼痛患者中冷却射频成本更低且QALY更高,骨关节炎患者中未见此优势。
核心结论
- 两种射频治疗在约22%患者中实现12个月疼痛减轻≥50%。
- 在持续性术后疼痛患者中,冷却射频似乎比传统射频更有效,且成本更低。
- 在骨关节炎患者中,冷却射频未显示优于传统射频的成本效果。
研究设计与样本
- COCOGEN试验为双盲、非劣效、预试验随机对照试验,按1:1随机分组。
- 纳入49例慢性膝痛患者,其中41例完成12个月随访。
- 比较冷却射频与传统射频治疗膝神经,随访至12个月,并进行12个月社会视角的试验性经济评价。
主要发现
- 12个月疼痛减轻≥50%的比例:传统射频组22.2%(4/18),冷却射频组22.7%(5/22),p>0.05。
- 持续性术后疼痛患者中,冷却射频与传统射频在12个月平均绝对NRS评分上差异有统计学意义(p=0.02)。
- 其他结局差异无统计学意义,未发生严重不良事件。
- 经济分析显示持续性术后疼痛患者中冷却射频成本更低且QALY更高,骨关节炎患者中无此结果。
临床怎么用
- 对于全膝关节置换术后持续性术后疼痛的慢性膝痛患者,冷却射频可能较传统射频更具效果且成本更低。
- 对于骨关节炎相关慢性膝痛,两种射频治疗12个月疗效相近,选择需结合其他因素。
局限性
- 本研究为预试验,样本量较小(纳入49例,完成12个月随访41例)。
- 持续性术后疼痛冷却射频组有1例患者在12个月随访时存在大量缺失数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Radiofrequency (RF) treatment of the genicular nerves reduces chronic knee pain in patients with osteoarthritis (OA) or persistent postsurgical pain (PPSP) after total knee arthroplasty (TKA). The objective of this study is to compare long-term outcomes of cooled and conventional RF and perform an economic evaluation. METHODS: The COCOGEN trial is a double-blinded, non-inferiority, pilot, randomized controlled trial that compared the effects up to 12 months of cooled and conventional RF in patients with chronic knee pain suffering from OA or PPSP after TKA following a 1:1 randomization rate. Outcomes were knee pain, functionality, quality of life, emotional health, medication use, and adverse events. A trial-based economic evaluation was performed with a 12-month societal perspective. Here, the primary outcome was the incremental costs per quality-adjusted life year (QALY). RESULTS: 41 of the 49 included patients completed the 12-month follow-up. One patient in the PPSP cooled RF group had substantial missing data at 12-month follow-up. The proportion of patients with ≥50% pain reduction at 12 months was 22.2% (4/18) in patients treated with conventional RF versus 22.7% (5/22) in patients treated with cooled RF (p>0.05). There was a statistically significant difference in the mean absolute numerical rating scale at 12 months after cooled RF and conventional RF in patients with PPSP (p=0.02). Differences between other outcomes were not statistically significant. The health economic analysis indicated that cooled RF resulted in lower costs and improved QALYs compared with conventional RF in PPSP but not in OA. There were no serious adverse events. CONCLUSIONS: Both RF treatments demonstrated in approximately 22% of patients a ≥50% pain reduction at 12 months. In patients with PPSP, contrary to OA, cooled RF seems to be more effective than conventional RF. Additionally, cooled RF has in patients with PPSP, as opposed to OA, greater effectiveness at lower costs compared with conventional RF. TRIAL REGISTRATION NUMBER: NCT03865849.
引用
- Belba A, Vanneste T, Kallewaard JW, et al. Cooled versus conventional radiofrequency treatment of the genicular nerves for chronic knee pain: 12-month and cost-effectiveness results from the multicenter COCOGEN trial. Reg Anesth Pain Med. 2025. PMID: 38388017. doi:10.1136/rapm-2023-105127
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。